dosing for tirzepatide dosage chart in ml: complete conversion guide every concentration Tirzepatide (Month 1) 2.5mg |

Clinical trials demonstrated average weight reductions of 15-21% of body weight over 72 weeks in people with obesity (SURMOUNT-1), while more modest weight loss was observed in type 2 diabetes patients (SURPASS trials)

The most commonly reported side effects are mild to moderate gastrointestinal symptoms such as nausea, constipation, and indigestion, and they usually ease as your body adjusts

2 Likes AustraliaLongevity May 31, 2025, 11:56am #77 Do you measure waist to hip ratio

Zepbound doesn't

Rosiglitazone monotherapy in mild-to-moderate Alzheimers disease: results from a randomized, double-blind, placebo-controlled phase III study

12mg weekly dose The highest dose tested produced 24.2% body weight loss at 48 weeks